Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
2367
result was found. Results that relate to
M
Ischemic bowel disease caused by compound Huangdai tablets: a case report
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(8):960-964.
1191 times
310 times
JIN Hao
SONG Yulin
YAO Yanxue
LI Ting
WANG Yanyan
Ische
m
ic colitis
Co
m
pound Huangdai Tablets
Adverse drug reaction
Details
Exploring the mechanism of Wendan decoction in treating adolescent depression based on network pharmacology and molecular docking technology
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1261-1269.
1454 times
422 times
YU Yuanhong
ZHANG Di
Adolescent
Depression
Wendan decoction
Network phar
m
acology
M
olecular docking
Details
Exploring targets and molecular mechanisms ofZanthoxyli Pericarpium components against hepatocellular carcinoma based on network pharmacology and molecular docking
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1270-1286.
2659 times
1188 times
WANG Jiawen
ZHAO Xiangxuan
XU Shu
Zanthoxyli Pericarpiu
m
Network phar
m
acology
Network targets
Hepatocellular carcino
m
a
M
echanis
m
of action
M
olecular docking
Details
Construction and preliminary evaluation ofN-acetylgalactosamine/cyclic peptide co-modified nucleic acid drugs for hepatocellular carcinoma treatment
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1287-1296.
1446 times
372 times
YANG Xuehua
XUE Song
LIU Zhengping
MAO Kaifan
ZHANG Hongqian
LI Dawei
ZHANG Daizhou
GalNAc
iRGD
Nucleic acid drug
Hepatocellular carcino
m
a
GalNAc-siPLK1-iRGD
Details
The influence of fresh cutting and traditional cutting on the quality of Radix Isatidis decoction pieces
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1297-1307.
1422 times
400 times
LU Shasha
WANG Ning
BAI Zhongjie
WANG Yumei
NAN Minmin
Radix Isatidis
Fresh cutting
Traditional cutting
Content deter
m
ination
M
icroscopic identification
Details
Optimization of extraction process for Chuanhu Qutong granules
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1308-1314.
1383 times
419 times
WANG Yonggang
HAO Haoqi
LIU Zhenyuan
WANG Pengfei
ZHENG Xuejie
ZHANG Cuiyun
HE Fengcheng
FAN Jianwei
GUAN Yongxia
Chuanhu Qutong granules
Orthogonal experi
m
ental design
E
m
odin
Transfer rate
Extract yield
Extraction process
Details
Quality study of Jingzhu Qingjie granules based on characteristic chromatogram and content determination
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1315-1321.
1407 times
370 times
QI Miao
OUYANG Xiye
DUAN Yungao
ZHU Xiaoyan
ZHANG Yi
CHEN Shu
ZHOU Kaifa
ZHOU Jing
CHEN Peng
Jingzhu Qingjie granules
Characteristic chro
m
atogra
m
Forsythoside A
Arctiin
Content deter
m
ination
Details
Determination of related substances in the Intermediate M-Ⅰof relugolix by HPLC
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1322-1328.
1406 times
326 times
WANG Fan
LIU Min
YANG Haixia
ZHANG Zonglei
LIU Yanxin
LIAN Zhenxia
WANG Jing
LI Xia
HPLC
Related substances
Inter
m
ediate
M
-Ⅰ of relugolix
Details
Residues of paclobutrazol and ochratoxin A in Yangyin Qingfei syrup
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1329-1337.
1436 times
348 times
WANG Fei
LIU Xin
LI Qing
WU Fang
LIANG Jialong
SUN Zhiyong
YANG Xiaoli
LUO Dingqiang
Yangyin Qingfei syrup
Paclobutrazol
Ochratoxin A
LC-
M
S
LC-FLD
Details
Analysis and health risk assessment of heavy metals and harmful elements in Dahuoluo pills based on ICP-MS method
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1338-1348.
1391 times
331 times
XIA Qiaohong
ZHANG Mingtong
CHANG Qi
LIU Xiaoyan
Dahuoluo pills
ICP-
M
S
Heavy
m
etals and dangerous ele
m
ents
Health risk assess
m
ent
Details
A comparative study of FICA and HPLC method for the determination of valproic acid concentration in plasma
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1357-1362.
1344 times
315 times
AO Li
MA Shaoxiang
YANG Ting
ZI Ruchun
RUAN Dongchun
YAO Qin
Valproic acid
Therapeutic drug
m
onitoring
HPLC
Fluorescence i
m
m
unochro
m
atographic assay
Details
Study on the inspection method ofLonicerae flos in Jinju Wuhuacha granules
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1363-1367.
1351 times
311 times
PAN Zhiwen
GUO Haibin
CHEN Yihua
Jinju Wuhuacha granules
Lonicerae Flos
M
acranthoidin B
UPLC-
M
S/
M
S
Details
Neurotoxicity characteristics comparison between cefepime and third-generation cephalosporins based on the FAERS database
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1368-1377.
1380 times
312 times
WEI Cheng
LI Boren
PAN Xiaoyan
WANG Yinglian
WEI Wu
Cefepi
m
e
Third-generation cephalosporins
Neurotoxicity
FAERS database
Propensity score
m
atching
Phar
m
acovigilance
Details
Comparative safety analysis of epcoritamab and glofitamab in the treatment of diffuse large B-cell lymphoma based on the FAERS database
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1378-1387.
1286 times
284 times
WANG Tao
SUN Hui
DAI Jie
SHI Hui
Epcorita
m
ab
Glofita
m
ab
Adverse drug events
Disproportionality analysis
Clinical priority assess
m
ent
Details
Mining and analysis of adverse drug event signals related to movement disorders in the pediatric population based on the AEMS database
Published on
Frontiers in Pharmaceutical Sciences
2026,30(8):1388-1395.
1314 times
280 times
DI Panpan
XING Xiaoqin
LIANG Hai
JIA Shuyun
HU Yunfei
M
ove
m
ent disorder
Adverse drug events
AE
M
S database
Disproportionality analysis
Pediatric population
Details
上一页
1
2
149
150
151
152
153
154
155
156
157
158
下一页